Literature DB >> 30343296

Comparison of Clinical and Laboratory Characteristics of General Paresis and Non-Neurosyphilis Dementia.

Man-Li Tong1,2, Yu-Yan Chen1,3, Xiao-Zhen Zhu1, Kun Gao1,2, Hui-Lin Zhang1,2, Wei-Hong Zheng1,2, Hui-Rong Wang1, Li-Li Liu1,2, Yong Lin1,2, Li-Rong Lin1,2, Tian-Ci Yang4,5.   

Abstract

BACKGROUND: The differential diagnosis of general paresis (GP) and non-neurosyphilis (NS) dementia is not clearly defined. The present study examined the differences in clinical and laboratory features of GP and non-NS dementia.
MATERIALS AND METHODS: We retrospectively examined clinical and laboratory features of 85 GP patients and 196 non-NS dementia patients. Data were collected from Zhongshan Hospital between June 2005 and June 2014.
RESULTS: The GP group had a higher percentage of males (83.53%, 71/85) and younger median age ([52 [interquartile range 47.0-61.0] vs. 76 [68.3-82.0] years) than the non-NS dementia group. GP have higher Mini-Mental State Examination (MMSE; Z = -5.809; p = 0.000) than non-NS dementia. Distribution of CDR scores were significantly higher in the non-NS group than GP group (χ2 = 29.153; p = 0.000). The laboratory findings showed significantly different total cholesterol (CH), low-density lipoprotein CH and homocysteine levels between the 2 groups. Serologic testing for syphilis revealed that the GP group had higher seropositive rapid plasma reagin (RPR) and Treponema pallidum particle agglutination (TPPA) rates than the non-NS dementia group (96.47% [82/85] vs. 0.51% [1/196], Z = -2.663, p = 0.008; 100% [85/85] vs. 1.02% [2/196], Z = -2.663, p = 0.008). Interestingly, cerebrospinal fluid (CSF) biochemical indices, including pleocytosis rates, increased protein levels, and positive RPR and TPPA rates in the GP group were higher than that in the non-NS dementia group.
CONCLUSIONS: Based on these preliminary data, patients with clinically evident symptoms of dementia, especially middle-aged males, should undergo blood tests for syphilis. All patients with positive serology results should undergo CSF examinations to diagnose GP dementia before further pharmaceutical and behavioral interventions.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Dementia; Differential diagnosis; General paresis; Neurosyphilis

Mesh:

Year:  2018        PMID: 30343296     DOI: 10.1159/000493866

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  3 in total

1.  Clinical and Laboratory Characteristics of Symptomatic and Asymptomatic Neurosyphilis in HIV-Negative Patients: A Retrospective Study of 264 Cases.

Authors:  Wurong Li; Meijuan Jiang; Dongmei Xu; Cheng Kou; Lei Zhang; Junhua Gao; Kaiyu Qin; Wenqing Wu; Xinghu Zhang
Journal:  Biomed Res Int       Date:  2019-05-06       Impact factor: 3.411

2.  Clinical Manifestations, Fluid Changes and Neuroimaging Alterations in Patients with General Paresis of the Insane.

Authors:  Jun-Hua Gao; Wu-Rong Li; Dong-Mei Xu; Bo-Wen Zheng; Yu-Ming Huang; Wen-Qing Wu; Wei Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2021-01-13       Impact factor: 2.570

3.  Ceftriaxone compared with penicillin G for the treatment of neurosyphilis: study protocol for a multicenter randomized controlled trial.

Authors:  Fang-Zhi Du; Min-Zhi Wu; Xu Zhang; Rui-Li Zhang; Qian-Qiu Wang
Journal:  Trials       Date:  2022-10-01       Impact factor: 2.728

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.